DXDongsheng Xu

Dongsheng Xu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dongsheng Xu has a total of 3 co-authors. Here are the top co-authors by number of shared publications:

  • Bethany Tierno

    From the Department of Pathology and Laboratory Medicine, Boston Medical Center, Boston, Mass

    1 shared publication
  • Farhad Askarian

    Department of Pathology and Laboratory Medicine, Boston Medical Center, Boston, Massachusetts 02118, USA

    1 shared publication
  • Fernando Chaves

    From the Department of Pathology and Laboratory Medicine, Boston Medical Center, Boston, Mass

    1 shared publication

Latest Publications

  • Dual surface immunoglobulin light-chain expression in B-cell lymphoproliferative disorders.

    by Dongsheng Xu

    Mature B lymphocytes exhibit allelic exclusion in which only a single class of immunoglobulin heavy chain and a single class of light chain, either kappa or lambda, are expressed. There have been several reports indicating that double light-chain gene rearrangements or dual light-chain expression can occur in B-cell malignant neoplasms, including chronic lymphocytic leukemia. Currently, it is a common notion that demonstration of light-chain restriction in a B-cell population is generally considered proof of monoclonality and indicates malignancy. To increase awareness of the existence of the dual kappa/lambda immunoglobulin light-chain expressing B-cell leukemia/lymphoma, to emphasize the importance of visual inspection of flow cytometric data, and to present the guidelines for flow cytometric interpretation of dual kappa/lambda coexpressing populations. Through comprehensive literature review, this article discusses the current understandings regarding the dual light-chain expression in B-cell neoplasms, the cellular and molecular mechanisms, and the clinical and diagnostic implications of dual light-chain expression. Dual kappa/lambda light-chain expressing B-cell leukemia/lymphomas do exist. Recognition of the dual kappa/lambda light-chain expression on B cells has diagnostic implication in leukemia/lymphoma immunophenotyping.


  • Open Access

    Dual Surface Immunoglobulin Light-Chain Expression in B-Cell Lymphoproliferative Disorders

    by Dongsheng Xu

    Context. —Mature B lymphocytes exhibit allelic exclusion in which only a single class of immunoglobulin heavy chain and a single class of light chain, either κ or λ, are expressed. There have been several reports indicating that double light-chain gene rearrangements or dual light-chain expression can occur in B-cell malignant neoplasms, including chronic lymphocytic leukemia. Currently, it is a common notion that demonstration of light-chain restriction in a B-cell population is generally considered proof of monoclonality and indicates malignancy. Objective. —To increase awareness of the existence of the dual κ/λ immunoglobulin light-chain expressing B-cell leukemia/lymphoma, to emphasize the importance of visual inspection of flow cytometric data, and to present the guidelines for flow cytometric interpretation of dual κ/λ coexpressing populations. Data Sources. —Through comprehensive literature review, this article discusses the current understandings regarding the dual light-chain expression in B-cell neoplasms, the cellular and molecular mechanisms, and the clinical and diagnostic implications of dual light-chain expression. Conclusions. —Dual κ/λ light-chain expressing B-cell leukemia/lymphomas do exist. Recognition of the dual κ/ λ light-chain expression on B cells has diagnostic implication in leukemia/lymphoma immunophenotyping.


  • Adrenal enlargement and insufficiency: A common presentation of intravascular large B-cell lymphoma

    by Farhad Askarian, Dongsheng Xu

    Intravascular large B‐cell lymphoma (IVLL) is a rare subtype of extranodal diffuse large B‐cell lymphoma and is very difficult to diagnose in patients antemortem due to nonspecific presentation of the disease. We report a case of IVLL in a 68‐year‐old white female who presented with 3‐month history of fever of unknown origin (FUO), night sweat, and weight loss. Laboratory tests revealed bilateral adrenal enlargement and adrenal insufficiency. IVLL was diagnosed only at autopsy. A review of the English language medical literature indicates that it is not uncommon for IVLL presented initially with FUO, bilateral adrenal enlargement, and adrenal insufficiency. We present this case to call for heightened awareness of the possibility of IVLL, particularly in an elderly woman who presents with FUO, bilateral adrenal enlargement, and adrenal insufficiency. The pathophysiologic mechanisms of adrenal insufficiency in IVLL are also discussed. Am. J. Hematol. 81:411–413, 2006.


  • Open Access

    Neutrophil Volume Distribution Width: A New Automated Hematologic Parameter for Acute Infection

    by Fernando Chaves, Bethany Tierno, Dongsheng Xu

    Context. —The number of band forms and immature neutrophils increases during acute bacterial infection. However, the determination of band counts and other neutrophil morphologic changes, such as the presence of toxic granulation, toxic vacuolization, and Dohle bodies in the cytoplasm, is labor intensive and time consuming, as it requires manual examination by an experienced medical technologist. Objective. —To investigate the value of the neutrophil volume distribution width (NDW), generated by VCS technology of the Coulter LH 750 hematology analyzer, as an additional predictor of acute infection. Design. —Total white blood cell count, percentage of neutrophils, and NDW data from 70 patients with positive blood cultures for bacteria and from 35 age-matched control subjects were retrospectively analyzed. Results. —A significant increase in the NDW was observed in the bacteremic patients compared with the controls (24.7 ± 4.5 vs 19.0 ± 1.5; P < .001). Such increase was observed even in patients with white blood cell counts less than 11 000/μL (23.0 ± 5.6 vs 19.0 ± 1.5; P < .001) or with percentages of neutrophils less than 85% (24.0 ± 4.9 vs 19.0 ± 1.5; P < .001). The more dramatic increases were seen in patients with leukocytosis (25.7 ± 3.2, P < .001) or with neutrophilia (25.9 ± 3.4, P < .001). Using an NDW cutoff of 23, a 100% specificity and a 69% sensitivity were achieved. Conclusions. —As a quantitative parameter, the NDW has potential for use as an additional indicator for diagnosing acute infection.